INTRODUCTION

Adoptive transfer of anti-CD19 Chimeric Antigen Receptor (CAR)-T cells has demonstrated remarkable
efficacy in treating patients with B cell acute lymphoblastic leukemia (B-ALL), chronic lymphocytic leukemia (CLL) and other indolent lymphomas [1] [2] [3] [4] . Despite the demonstrated success, there exist large variation of responses and unpredictable toxicity in patients 5, 6 , which could be attributed in part to interpatient and intra-population heterogeneity of CAR-T infusion product, requiring a higher resolution approach to characterize not only phenotypic composition but the function of CAR-T cells at the systems level. The scFv ectodomain of CAR binds to CD19 expressed on the surface of a target tumor cell and transmits signal via the transmembrane linker to the intracellular signaling domain such as CD3z to elicit T-cell activation independent of signaling from T-cell receptor (TCR)-mediated binding to peptide major histocompatibility complex (p-MHC) 7 . Incorporating a co-stimulator domain such as CD28 or 4-1BB (CD137) in the second generation CAR further enhanced proliferation, persistence, and potency 8 .
Therefore, the mechanism of CAR-T activation could differ substantially from that of classic T cells. But it remains inadequately characterized as of today. The questions like how different CAR-T cell subsets such as CD4 helper vs CD8 cytotoxic cells respond to CAR stimulation, how the polarization subtypes such as T H 1, T H 2, T reg , etc. differentially control CAR-T cell responses, how the differentiation status could affect the activation state, are all yet to be fully elucidated.
Current methods for evaluating CAR-T cell activation include the measurement of IFNg secretion
by ELISA or the detection of IFNg-secreting cells by ELISpot 9, 10 . Multiparameter flow cytometry was used for immunophenotyping of CAR-T cells, which is one of the mainstay techniques used for monitoring CAR-T product manufacturing, but the number of markers and functions (cytokines) it can measure is limited 11, 12 . Intra-cellular cytokine staining for flow cytometric analysis is not a true secretion assay and often leads to over-estimation of cytokine-secreting cells. Recently, Xue et al. used single-cell multiplex cytokine profiling to measure the cytokine output of CD19-BB-3z CAR-T cells using CD19-coated beads and revealed a diverse polyfunctional response upon activation 13 . However, the cytokine profile of a CAR-T cell is yet to be directly correlated to cytotoxicity, subtype and signaling in order to elucidate the underlying mechanisms.
Herein, we use high-throughput single-cell 3' mRNA transcriptome sequencing, single-cell multiplex cytokine secretion assay, together with live cell imaging of cytotoxic activity to interrogate third-generation anti-CD19 4-1BB/CD28/CD3ζ (CD19-BB-28-3z) CAR-T cells, yielding the first comprehensive portrait of single-cell level transcriptional and cytokine signatures of CAR-T cells upon antigen-specific stimulation. A range of cytokines are produced in single CAR-T cells in direct correlation with cytotoxicity, irrespective of CD4 + 'helper' vs CD8 + cytotoxic cell types. Single-cell analysis reveals that the predominant response is a highly mixed T H 1/T H 2 function in the same cell that also produce granulocyte-macrophage colony stimulating factor (GM-CSF). Regulatory T cell (T reg ) activity, although observed in a small fraction of activated cells, emerges from this hybrid T H 1/T H 2 population. Surprisingly, the cytokine response is minimally associated with differentiation status although all major subsets such as naïve, central memory, effector memory, and effector cells are detected.
Our study suggests that the activation of CAR-engineered T cells is a canonical process associated with a highly mixed multi-functional response, supporting the notion that 'polyfunctional' CAR-T cells correlate with objective response of Non-Hodgkins Lymphoma patients reported in a CD19 CAR-T clinical trial 14 .
RESULTS AND DISCUSSIONS
Study design: single-cell level measurement of transcriptional, cytokine, and cytotoxic function.
We combined a set of single-cell techniques to interrogate CAR-T cells upon antigen specific stimulation (Figure 1a ) in order to quantitatively dissect the correlation of activation states with T-cell subtypes, differentiation, and other factors such as intracellular signaling cascades, co-stimulators and immune checkpoints. CAR-T cells used in this study were manufactured through ex vivo transduction of autologous T cells with a CD19-BB-28-3z CAR construct, expansion for ~10 days using CD3/CD28
Dynabeads, and then purification by bead removal and enrichment for CAR expression. T cells were isolated from three healthy donors and for the purpose of this study the human B-cell lymphoma Raji cell line was used as a target. Single-cell 3' mRNA transcriptome profiling was performed using a massively parallel cell barcoding method 15 implemented in a bead-in-a-well microchip. Single CAR-T cell cytolytic activity was measured by co-seeding CAR-T cells and target tumor cells in the microwell array to image the uptake of SYTOX Green nucleic acid dye 16 indicative of target cell lysis by CAR-T cells. Single-cell multiplex cytokine secretion assay was performed using a previously developed antibody barcode microchip assay [17] [18] [19] , which was further modified in this study to co-measure cytotoxicity by seeding both CAR-T and tumor cells in the same single-cell protein secretion assay microchamber. Integrating all these single-cell analyses tools provides an unprecedented resolution to correlate the activation states such as anti-tumor cytotoxicity and cytokine response in single CAR-T cells to their phenotype, differentiation, signaling, and other characteristics.
CAR activation leads to heterogeneous responses involving a range of cytokines, correlating directly to cytotoxicity
Prior to conducting single-cell analyses, a population LDH assay demonstrated these CAR-T cells are highly cytotoxic (60.02% at 1:1 and 90.1% at a 5:1 CAR-T:Target ratio) (Figure 1b) , confirmed by timelapse imaging of SYTOX Green uptake (Supplementary Figure 1a) , and concurrently correlated with the secretion of a panel of cytokines (e.g., IFNg, TNFa, GMCSF, IL4, IL5, IL8, and IL13) detected by a protein microarray assay (Supplementary Figure 1b) . Single-cell massively parallel 3' mRNA sequencing was conducted with unstimulated alone CAR-T cells (Ctrl) and stimulated CAR-T cells (replicates: CMB1 and CMB2). The stimulated cells were prepared by co-culturing with CD19-expressing target cells for 6 hrs and then purified by magnetically cell sorting to remove target cells). The sequencing data were of high quality (Supplementary Figure 2&3) and 3817 single CAR-T cell transcriptomes were obtained, which were visualized with t-Distributed Stochastic Neighbor Embedding (t-SNE) plots (Figure 1c upper panel) . We observed high consistency between replicates and highly efficient activation with <0.5% of activated CAR-T cells (red and green) residing in the Ctrl cluster (blue). This is consistent with previous findings 13 and supports the hypothesis that CAR activation is largely independent of class 1 vs 2 p-MHC signaling. CAR-T cells with defined CD4:CD8 composition have been investigated to treat B-ALL patients and demonstrated high potency and allowed for delineating factors correlated with expansion, persistence and toxicity 22 . Our results confirmed the importance of CD4 cells in CAR-T product and the necessity to fully evaluate the role of these "helper" T cells in immunotherapy.
Mapping into subtypes reveals a predominantly mixed T H 1/T H 2 response in conjunction with T reg activity in the same CAR-T cells
To access whether the observed heterogeneous activation depends on CAR-T cell polarization and subtypes, we examined the expression of master transcription factors(TFs) and signature cytokines. Both IFNg is produced from 85.6% of cells, suggesting the interferon response is also elicited or amplified by T-bet-independent pathways, for example, STAT1. GATA3 is expressed in 64.3% of cells but the predominant T H 2 cytokine IL4 is produced by 23.1% of these cells whereas other T H 2 cytokines (66% IL5+ and 80.6% IL13+) are more predominant, indicative a prevalent but slightly skewed T H 2 response, consistent with previous report that IL13 rather than IL4 is the dominant T H 2 cytokine observed in CD19-BB-3z CAR-T cell activation 13 . Thus, for further analysis IL13 rather than IL4 was chosen as the T H 2 dominant cytokine. Figure 2g) . Therefore, CAR-T cell activation appears to differ substantially from classic T cells in that the predominant response is a highly mixed T H 1 / T H 2 phenotype, within which a fraction of cells further exhibit regulatory activity, presumably to counteract over-activation (Figure 2h) . 25 , which may explain in part the notion that CAR-T cells in general show a balanced response in anti-tumor effector and inflammatory toxicity despite the unusually wide range of cytokines co-produced per cell.
GM-CSF is highly prevalent in activated CAR-T cells and co-produced with Type 1 and 2 cytokines
GM-CSF is a potent proinflammatory cytokine involved in the recruitment, maturation and activation of myeloid cells 26 . The helper T cells producing GM-CSF have been identified and recently reported to serve a nonredundant function in autoimmune pathogenesis, arguably representing a unique helper T cell subset 27 . Our data showed that >80% of activated CD4 + cells express GM-CSF, confirmed
independently by single-cell cytokine secretion (proteome) and single-cell mRNA sequencing (transcriptome) (Supplementary Figure 6) . GM-CSF production is associated with both Type 1 (IFNg) and Type 2 (IL5) responses. We observed that 89% of T-bet + cells and 83.5% of GATA3 + cells produce GM-CSF. Previously, it was found that STAT5 programs a distinct subset of GM-CSFproducing T H cells in neuroinflammation and autoimmunity 28 . In this work, 65.2% of GM-CSFexpressing CD4 + CAR-T cells are negative or low for STAT5. Instead, we observed the expression of a wide range of STATs, but STAT1 is predominant, which may contribute to the profound T H 1 interferon response despite a modest level of T-bet expression. However, Gene Set Enrichment Analysis (GSEA) confirmed the relevance of STAT5 signaling and also revealed the importance of IL6/STAT3 (Supplementary Figure 7) , which has been observed as a determinant of CAR-T memory phenotype and therapeutic persistence in patients 29 . Finally, the JAK/STAT signaling relies on phosphorylation of STATs and their nuclear translocation. The mechanism leading to a prevalent GM-CSF-producing phenotype in activated CAR-T cells is yet to be further investigated.
Cytokine production in CAR-T cells upon antigen-specific activation is minimally dependent on differentiation status
To To investigate the possible relationship between CAR-T cell activation and the changes in co-stimulators and immune checkpoints, we examined their expression in single-cell transcriptomes. We observed that CTLA4 is the most upregulated among all immune checkpoints upon CAR activation (Figure 4a) . PD-1 demonstrates a similar trend but its expression level is low and the frequency is only 9.8% in CD4 + and 3.7% in CD8 + subsets. PD-1 is also the primary marker of T cell exhaustion 32 and thus our data suggest an Figure 8) , we observed significant increase of IL10 expression in CD4 + subset and TGFb expression in CD8 + subset whereas all other cytokines are minimally or insignificantly correlated with CTLA4, suggesting a possible mechanism for CAR-T cells to control immune homeostasis without developing distinct regulatory subtype, which has important implication in combining checkpoint blockage and CAR targeted immunotherapies [33] [34] [35] .
CONCLUSIONS
We use high-throughput single-cell 3' mRNA transcriptome sequencing, multiplexed single-cell cytokine secretion assay, together with live cell imaging of cytolytic activity to interrogate third-generation anti- 
METHODS
Cell Culture and Labeling
Human anti-CD19scFv-CD28-4-1BB-CD3ζ (Promab) T cells were cultured in complete X-Vivo 10 
Bulk LDH cytotoxicity assessment
Cytotoxicity was assessed using the Pierce LDH Cytotoxicity Assay kit (Thermo). The effector: target ratios surveyed are 1:1, 5:1, and 10:1. Target and effector cells were maintained in complete RPMI medium at a final concentration of 0.7x10 6 cells/ml. LDH release was measured in the supernatant according to manufacturer's instructions. Briefly, effector and target cells were incubated as described above for a six-hour period. Maximum LDH release was measured in target cells incubated with the provided 10X lysis buffer. Target cell cytotoxicity was calculated using the following formula: %Cytotoxicity = 100*[(Car + : Raji -Car + alone -target alone)/(Maximum target lysis -target alone)].
Population Sytox Green Cytotoxicity Assay
Effector CAR-T cells and labeled target cells were co-cultured in a 96 well U-bottom plate. Three effector:
target concentrations were surveyed: 1:1, 5:1, and 10:1. Raji cell concentration was kept at 10,000 cells/ml while the concentrations of CAR + cells were as follows 10,000 cells/ ml, 50,000 cells/ ml, and 1,000,000 cells/ml for each different ratio mentioned above. To distinguish cell death, SYTOX (green) (Invitrogen) was added to each well according to manufacturer's instructions. Images were taken at 0, 4, 6, 10 hours using the Nikon Eclipse Ti microscope.
Single CAR-T cell cytotoxicity assay in a microwell array 100 µm x 100 µm nanowell array was prepared by curing poly(dimethyylxiloxane) PDMS (Dow Corning) on a silicon wafer master with the etched array design. The nanowell array was cut to fit within the well of a 24 well plate and it was surface treated with oxygen plasma prior to cell loading to decrease PDMS hydrophobicity 36 . Labeled Raji (T) and CAR cells (E), as described above, were seeded at a density of 100,000 cells/ ml. Stochastic distribution of the cells within the array allowed for a range of E:T ratios.
Images were acquired on a Nikon Eclipse Ti microscope fitted with an incubation chamber (37 °C, 5%
CO 2 ) using a 10x/0.3 objective. Automated multi-loci images were taken at 15 min intervals for a total duration of 10 hours. Images were processed using the built-in Nikon software. Paired t-tests were used to determine P values as described in the legend of Figure 2 .
Fabrication of antibody barcode array slides and single-cell microchamber array chip
A panel of 14 antibodies (IL-2, IL-4, IL-5, IL-6, IL-8, IL-10, IL12p70, IL-13, IL-17a, Granzyme-b, TNF-α, TNF-β, IFN-γ, GM-CSF, and FITC-BSA (alignment control) (R&D) was patterned onto a poly-l-lysine glass slide using an air-pressure driven flow through a PDMS mold with 20 microfluidic channels. The PDMS mold was fabricated in-house as previously described 17, 18 . The subnanoliter microchamber array for cell capture contains 14 columns of 220 wells and was fabricated into a PDMS slab. Prior to cell loading the microchamber PDMS slab was treated with oxygen plasma and then topped with RPMI medium.
Single-cell cytokine secretion profiling using antibody barcode chips, data collection and analysis
Following labeling, CAR and Raji cells were incubated at a 1:1 ratio for 15 minutes in RPMI medium supplemented with SYTOX (green) to final concentration of 0.2 µM and the suspension was then gently pipetted on the microchamber array. The SCBC was assembled by overlaying the 14-plex antibody barcode glass slide and secured using our clamping system. The SCBC assay was imaged (Nikon Eclipse Ti) once at 0 hours and then following a 14-hour incubation (37 °C, 5% CO 2 ) was imaged a final time.
Cell number (CD4+ CAR, CD8+ CAR, and Raji cells), cell-to-cell contact, and Raji death was recorded for each microchamber from the phase-contract and fluorescent images. After the 14 hour incubation, the antibody barcode chip was developed using an ELISA sandwich immunoassay as previously described 18 .
The developed slides were scanned using the GenePix 4200A microarray scanner (Axon).
Single-cell cytokine profile data quantification and informatics analysis
The fluorescent signals were processed using the GenePix software and a custom Excel macro to determine the average fluorescent signal for each secreted cytokine. The threshold gate (background) used for cytokine intensity normalization was calculated by (average of raw mean fluorescence intensity of a given cytokine for the 0-cell wells) + 2× (standard deviation of raw mean fluorescence intensity of a given cytokine for the 0-cell wells) 37 . Secretors were defined as cells in the microchambers where the corresponding fluorescence cytokine signal intensity was higher than the threshold. We performed log transformation on the normalized cytokine intensity values (secretor raw fluorescence intensity for each cytokine -threshold gate for each cytokine) and used analysis and graphical tools applied single-cell analysis and graphical tools to visually represent such large-scale high-dimensional data such as PCA and viSNE 38 . All single-cell secretomic analysis was performed using our custom-built algorithms in Excel, R, and MATLAB.
Population-level cytokine secretion measurement of CAR : Raji cell pairings
CAR-T cells were co-incubated with target cells, both at a density of 100,000 cells/ml, in triplicates in a u-bottom 96 well plate at a 1:1 E:T ratio. CAR-T and Raji alone controls were also included in the same well plate at the same concentration. After a 10 hour incubation, the cell suspension was pelleted at 200 g and the supernatant was removed and the population cytokine assay was performed as previously described.
17, 18
High-throughput scRNA-seq using a microwell array chip and data analysis
Our approach for massively parallel 3' mRNA sequencing of single cells was based upon a closed microwell array system for co-isolation of single cells and DNA barcode chip. The chemistry was modified from the previous publication 15 . Briefly, the cell suspension prepared as above was pipetted onto the inlet of our the flow cell of our microchip, in which ~15,000 microwells (40 micrometers in diameter) covered the entire bottom to allow for trapping of single cells. The cells were withdrawn into the device using a negative pressue applied to the outlet. Once the microwell array was filled with the cell solution, the fluid flow was stopped and cells were allowed to settle by gravity into the wells. Excess cells were washed out by PBS and mRNA capture beads were then loaded similarly to the cells. Excess beads were also washed out by PBS and then lysis buffer was introduced into the device. Fluorinated oil (Fluorinert FC-40) was withdrawn into the device to seal the wells. Following lysis, the microfluidic device was incubated for an hour inside a humidity chamber to allow mRNA capture onto the beads. Reverse transcription, library construction, and sequencing were performed as previously discussed. Sequencing libraries were constructed according to the Nextera tagmentation (Nextera XT, Illumina) manufacturer's protocol. The finished libraries were sequenced on the HiSeq 2500 sequences (Illumina). The transcripts were then aligned to the reference human transcriptome hg19 using STAR v2.5.2b. The resulting gene expression matrices were analyzed using the Seurat package in R studio, custom built algorithms in R, MATLAB, and Excel and GraphPad Prism was used for plotting. and Treg (IL10) was plotted.
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